No insider purchase over the last 90 days. The latest, by Johannes Emil Kjaersgaard Gadsboell, was filed 01 Apr 2026.
Pierce Group AB is a listed company. Its directors and officers file their transactions with Finansinspektionen. 1 insider has disclosed 3 filings since 25 October 2025.
Only purchases show up on the open market, 3 purchases in all worth €179k, filed by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The largest single trade was a purchase of €79k by Johannes Emil Kjaersgaard Gadsboell, published on 1 April 2026. On the buying side, the filings list 1 board member among the declarants.
The last insider purchase was made public on 1 April 2026, 208 days ago. The median gap between a trade and its publication by Finansinspektionen is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19).
For context, the typical company on the same exchange (median of 1,028 companies) published 9 filings over the same period, against 3 filings here. Since 2023, the database holds 10 purchases and no sales by insiders of the company.
Elsewhere in the same market, our signals recently picked up insider purchases at Dynavox Group AB and Rusta AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
· cache
11 of 11 declarations
Pierce Group AB is a company listed on the Stockholm Stock Exchange, specializing in the medical technology sector. It focuses on the development and commercialization of innovative solutions for the healthcare market.
Purchases our model currently ranks for the recommendations list.
All recommendations